Related Experiment Video
Updated: Mar 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The PKA/MBD2 Axis Transcriptionally Represses INPP5A to Modulate PI3K/Akt Signaling and Accelerate Pituitary
Qian Jiang1,2, Yaorui Wang1,2, Zihan Wang1,2
1Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei province, China.
Context And Objective:
The malignant progression of pituitary neuroendocrine tumors (PitNETs) is closely associated with abnormalities in the phosphoinositide signaling pathway. This study aims to investigate the regulatory role and molecular mechanism of inositol polyphosphate 5-phosphatase A (INPP5A) in the malignant progression of PitNETs, with a focus on its interaction with the PI3K/Akt signaling pathway and the epigenetic regulator MBD2.
Setting:
Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology.
Design:
Analyze genes related to IP3 metabolism in single-cell sequencing samples of PitNETs from NCBI, and perform immunofluorescence staining and statistical analysis on samples from 62 patients with PitNETs.
Result:
INPP5A was significantly downregulated in PitNETs, and its expression was negatively correlated with tumor invasiveness, Ki67 index, and volume, Overexpression of INPP5A inhibited tumor cell proliferation, migration, and hormone secretion, while knockdown of INPP5A promoted these malignant phenotypes, INPP5A negatively regulated the PI3K/Akt pathway by degrading IP3, MBD2 directly bound to the INPP5A promoter region to mediate transcriptional repression, Activation of PKA signaling phosphorylated MBD2 (at S99), recruited 14-3-3σ to stabilize the MBD2 protein, and enhanced the inhibition of INPP5A.
Conclusion:
INPP5A acts as a tumor suppressor gene in PitNETs, and its downregulation promotes tumor malignant progression by activating the PI3K/Akt pathway. MBD2 and its PKA-mediated phosphorylation are key mechanisms for INPP5A transcriptional repression. Targeting the MBD2-INPP5A-PI3K/Akt axis may provide a new strategy for the treatment of PitNETs.
Insights
Inositol polyphosphate 5-phosphatase A (INPP5A) suppresses pituitary neuroendocrine tumor (PitNET) growth by inhibiting the PI3K/Akt pathway. Its downregulation promotes malignancy, with MBD2 mediating repression.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Malignant progression of pituitary neuroendocrine tumors (PitNETs) is linked to phosphoinositide pathway dysregulation.
- Inositol polyphosphate 5-phosphatase A (INPP5A) role in PitNETs is unclear.
Purpose of the Study:
- Investigate INPP5A's regulatory role in PitNET malignant progression.
- Elucidate INPP5A's mechanism involving the PI3K/Akt pathway and MBD2.
Main Methods:
- Analyzed IP3 metabolism genes in PitNET single-cell sequencing data (NCBI).
- Performed immunofluorescence and statistical analysis on 62 PitNET patient samples.
Main Results:
- INPP5A was downregulated in PitNETs, correlating inversely with invasiveness and proliferation markers.
- INPP5A overexpression inhibited, while knockdown promoted, PitNET cell malignant phenotypes.
- INPP5A negatively regulated PI3K/Akt by degrading IP3; MBD2 repressed INPP5A transcription.
- PKA-mediated MBD2 phosphorylation stabilized MBD2, enhancing INPP5A repression.
Conclusions:
- INPP5A functions as a tumor suppressor in PitNETs, with downregulation activating PI3K/Akt.
- MBD2 and PKA-mediated phosphorylation are key to INPP5A transcriptional repression.
- The MBD2-INPP5A-PI3K/Akt axis presents a potential therapeutic target for PitNETs.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
IP3/DAG Signaling Pathway

